ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: SA-PO092

Viral Priming Enhances Kidney Injury at Early Time Points in Lipopolysaccharide (LPS)-Induced Sepsis-Associated AKI

Session Information

Category: Acute Kidney Injury

  • 103 AKI: Mechanisms

Authors

  • Odum, James D., The University of Alabama at Birmingham Heersink School of Medicine, Birmingham, Alabama, United States
  • Vollmer, Giacynta A., The University of Alabama at Birmingham Heersink School of Medicine, Birmingham, Alabama, United States
  • Akhter, Juheb, The University of Alabama at Birmingham Heersink School of Medicine, Birmingham, Alabama, United States
  • Bolisetty, Subhashini, The University of Alabama at Birmingham Heersink School of Medicine, Birmingham, Alabama, United States
Background

Sepsis-associated acute kidney injury (SA-AKI) is a heterogenous syndrome inflicted by the sepsis inflammatory cascade and phenotype-specific mechanisms. Viral priming followed by bacterial sepsis causes exaggerated inflammation and is associated with higher mortality than bacterial sepsis alone. We generated a novel murine SA-AKI model that recapitulates the viral primed bacterial sepsis phenotype using polyinosinic-polycytidylic (poly(IC)) acid, a synthetic viral double-stranded DNA analog, followed by low-dose lipopolysaccharide (LPS).

Methods

Using 8-week-old male C57BL/6J mice, we induced viral priming at 0h via poly(IC) intraperitoneal (IP) injection (10 mg/kg) vs. saline control. At 24h post-poly(IC), we administered low-dose LPS (0.5 mg/kg via) by IP injection vs. PBS control. We measured glomerular filtration rate (GFR) at 28h via FITC-sinistrin and sacrificed mice at 32h for collection of blood and urine. Analysis employed 2-way ANOVA; p<0.05 deemed significant.

Results

GFR was significantly reduced by 28h in poly(IC)+LPS (IC:LPS, 12.9±8.0 uL/min) mice compared to poly(IC)+PBS (IC, 223.3± 7.9 uL/min, p<0.001), saline+LPS (LPS, 117.4±31.4 uL/min, p=0.014) or control (Veh, 221.3±35.8 ml/min, p<0.001) mice. This corresponded to increased serum creatinine in IC:LPS mice at 32h compared to normal creatinine in other cohorts. At 32h, IC:LPS mice had significantly increased IL6 along with leukopenia and thrombocytopenia compared to LPS or Veh mice. Urine kidney injury molecule-1 was elevated in IC:LPS mice, but not in IC mice.

Conclusion

We generated a novel murine model to study mechanisms of viral primed SA-AKI. Poly(IC) alone does not cause kidney injury. Poly(IC)+LPS leads to early and significant kidney injury despite low dose LPS that has modest reduction in GFR with no changes in creatinine. Viral priming imparts a synergistic injurious response and warrants further investigation.